https://healthpromotionresearch.org/Regulatory-Science-and-Policy Parent Page: Regulatory Science and Policy id: -1 Active Page: Regulatory Science and Policyid:35840

Regulatory Science
and Policy

The TSET Health Promotion Research Center conducts groundbreaking research to help inform regulatory science and policy on a broad range of issues

Regulatory science applies research to guide policies and regulations, ensuring that public health is protected and promoted through evidence-based decision-making.

Search Policy Related Publications

The faculty at the TSET Health Promotion Research Center (HPRC) currently have written or co-written over 90 policy related publications. You may search by any of the descriptors below. To refine your search, you may search by multiple descriptors.

Search

Regulatory research at HPRC:

Dr. Lurdes Queimado examines the health effects of modifiable risk factors - such as tobacco, e-cigarette, and cannabis use - applying a broad array of state-of-the-art tools, including a novel DNA damage assay (q-PADDA) developed in her laboratory.

Dr. Amy Cohn examines the effects of menthol-flavored tobacco products and low nicotine cigarettes on addiction outcomes.

Dr. Zachary Massey conducts research in communication regulatory science concerning tobacco, alcohol, and cannabis products. This includes studying consumer product usage, interactions with packaging, and perceptions about labeling and health warning information.

Dr. Jason Oliver examines novel pharmacological, behavioral, and technology-based interventions for tobacco use, as well as how the tobacco regulatory environment contributes to the etiology of nicotine dependence.

Dr. Erin Vogel examines the effects of tobacco-related social media content and marketing claims on young people's perceptions of and intentions to use tobacco products.

Dr. Katelyn Romm examines sociocontextual influences of longitudinal trajectories of tobacco use among adolescents and young adults, as well as tobacco industry influences (e.g., advertising, marketing claims) on tobacco-related perceptions and use among young people.

Dr. Joanne Chen Lyu examines social media and mobile app interventions for tobacco cessation, as well as the advertising and marketing strategies the industry uses for novel nicotine products such as e-cigarettes and oral nicotine pouches.

The Regulatory Science Laboratories

Clinical laboratory 

The clinical laboratory includes four negative-pressure rooms and two control rooms for conducting human clinical research. The control rooms enable continuous monitoring of participants and are equipped with video capabilities. The laboratory is equipped with a variety of topography devices (e.g., e-cigarettes, tobacco, hookah) for both in-lab and field research. Routine collection of exhaled breath, saliva, blood, urine, and buccal samples supports numerous FDA- and NIH-funded studies and ensures that scientifically rigorous tools are employed to inform regulatory decisions.

Experimental Laboratory

Adjacent to the Clinical Laboratory, the HPRC Experimental Laboratory supports the processing, analysis, and storage of biological samples collected at the Clinical Laboratory. Currently, the laboratory processes over 500 samples annually using state-of-the-art equipment. Analyses performed include quantification of carbon monoxide (CO), nicotine, cotinine, and THC metabolites, as well as testing for illicit drug use and verification of abstinence. Following initial validation, samples stored in the HPRC Experimental Laboratory can be distributed to a variety of other experimental laboratories for studies including DNA damage and mutation analysis, RNA sequencing, gene and protein expression, and inflammation research.